Medtronic announces first patient implants of investigational implantable tibial neuromodulation therapy for bladder incontinence

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study...

Related Keywords

Ireland ,United States ,Dublin ,Yuna Lee ,Katie Genereux ,Mira Sahney ,Prnewswire Medtronic ,Ryan Weispfenning ,Leede Research ,Linkedin ,Department Of Economic ,Drug Administration ,United Nations ,Population Division ,Pelvic Health ,Exchange Commission ,Virginia Mason Medical Center ,Medtronic ,Our Mission ,Neuroscience Portfolio ,Social Affairs ,World Population Prospects ,National Association ,Prospective Study ,Evaluate Efficacy Using ,Tibial Neuromodulation System ,Patients With Overactive Bladder ,Medtronic Plc ,